Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details Narrative)

v3.24.3
Stockholders’ Equity (Details Narrative) - USD ($)
 12 Months Ended
Nov. 13, 2023
Sep. 28, 2022
Jun. 30, 2024
Jun. 30, 2023
Nov. 20, 2023
May 04, 2021
Subsidiary, Sale of Stock [Line Items]            
Financing fees     $ 62,354 $ 317,083    
Common stock, shares authorized     50,000,000 40,000,000    
Common stock, par value     $ 0.001 $ 0.001    
Preferred stock, shares authorized     2,000,000 0    
Preferred stock, par value     $ 0.001 $ 0.001    
Common Stock [Member]            
Subsidiary, Sale of Stock [Line Items]            
Issuance of common stock     300,000 2,264,650    
Common Stock [Member] | Loan And Sercurity Agreement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Issuance of common stock 300,000          
Minimum [Member]            
Subsidiary, Sale of Stock [Line Items]            
Common stock, shares authorized         40,000,000  
Maximum [Member]            
Subsidiary, Sale of Stock [Line Items]            
Common stock, shares authorized         50,000,000  
Private Placement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Issuance of common stock   2,264,650        
Stock issued during period, value, new issues   $ 6,600,000        
Stock issued value per unit   $ 2.935        
Proceeds from issuance or sale of equity   $ 6,300,000        
Financing fees   $ 300,000        
Warrant exercise price per share   $ 4.215        
IPO [Member]            
Subsidiary, Sale of Stock [Line Items]            
Common stock, shares authorized           40,000,000
Common stock, par value           $ 0.001
Preferred stock, shares authorized           2,000,000
Preferred stock, par value           $ 0.001